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Graves’ disease may lead to exophthalmos that is 
cosmetically unacceptable or causes visual loss. This has 
been managed surgically by external orbital decompression. 
However, a new minimally invasive endoscopic orbital 
decompression technique is now possible, with resection 
of the medial and posterior portion of the orbital limits 
requiring no cutaneous or gingival incisions. This technique 
produces decompression comparable to that obtained by 
external techniques. Endoscopic orbital decompression is 
a safe and effective procedure for the treatment of thyroid 
orbitopathy.
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INTRODUCTION
Graves’ Ophthalmopathy is an autoimmune disease 
characterized by deposition of antithyroglobulin immune 
complexes on the extra-ocular muscles. These complexes 
induce an inflammatory response through lymphocytes, 
mast cells and plasmatic cells, causing edema and fibrosis 
later on, with hypertrophy of the extra-ocular muscles - es-
pecially the inferior and middle rectus muscles and orbitary 
fat. Moreover, there is a stimulation of fibroblast-myogenic 
activity, resulting in an increase in orbital volume, causing 
proptosis, mainly. It is more common to women than men, 
with average age between 20 and 40 years1-3.
The most common clinical signs are proptosis - in 
different levels of intensity, asymmetrical or bilateral; and 
diplopia, because of the abnormal and asymmetrical mobil-
ity of extra-ocular muscles infiltrated by inflammatory cells. 
In more severe cases there is keratoconjunctivities, eyelid 
retraction and corneal ulcerations because of insufficient 
eyelid closure, and finally, optical neuropathy caused by 
a compression on the posterior third of ophthalmic nerve, 
at the orbital apex.
Orbital involvement occurs in about 50% of the 
patients with Graves’ disease, but only 5 to 10% of these 
develop severe ophthalmopathy.
The disease evolves slowly but progressively until 
it stabilizes, there are, however, rare cases of spontaneous 
resolution. Notwithstanding, those patients who develop 
severe proptosis or optical neuropathy require clinical or 
surgical treatment.
About two-thirds of the patients respond to other 
treatment modalities, specially if treated in the acute phase, 
treated with steroids, orbital radiation (which is not effi-
cient for proptosis and diplopia), immunesupressors and 
plasmapheresis. The acute phase lasts from 6 to 18 months, 
with orbital inflammation and congestion, increase in in-
traorbitary volume causing proptosis with anterior shifting 
of the eye ball. It evolves to a chronic and stable phase 
which may start from 18 months to 3 years after orbitopathy 
onset. In this phase, the fibrotic process sets in.
The orbitopathy seems to follow a different pathway 
from the thyroid treatment, and normally does not bear 
relation with the thyroid abnormalities. It may precede, fol-
low or even occur after hyperthyroidism, or even without 
clear hyperthyroidism.
Surgical treatment for Graves’ ophthalmopathy is 
used to treat the consequences of the disease and, there-
fore, is done during the disease stable phase. It is indicated 
whenever there are symptoms of ocular surface exposure, 
optical neuropathy or for cosmetic reasons. It includes re-
pairing strabismus, eyelid retraction and orbital decompres-
sion to correct exophthalmia6. The decompression major 
goals are to open more room to accommodate orbital con-
tent, thus reducing orbital tissue pressure; restore vision, 
allow the functioning of the extra-ocular muscles, eyelid 
closure and, consequently, reduce proptosis. There are 
cosmetic improvements. Different approaches have been 
described for orbital decompression: Lateral orbitotomy, 
frontal craniotomy, external fronto-ethmoidectomy, orbital 
transnasal decompression7-9. Through these approached 
we may remove the orbital medial or lateral walls, orbital 
floor, both the floor and medial wall, both floor and lateral 
wall, and anterior cranial fossa. Walsh-Ogura7 procedure, 
which uses a transnasal approach was the one most em-
ployed. Through a broad maxillary antrostomy we are able 
to remove the orbital floor, sparing the infra-orbitary nerve, 
followed by a transnasal ethmoidectomy and decompres-
sion of the medial orbital wall. However, it is an approach 
associated to Caldwell-Luc’s procedure morbidity and may 
result in inferior shifting of the eye ball, with access limita-
tions for the decompression of the orbital apex.
With the development of endoscopic surgery, the 
transnasal removal of the lamina papyracea has caused 
proptosis reduction comparable to the results of other 
approaches, with advantages. Described by Kennedy et 
al.10 and Michel et al.4. It allows excellent view without 
the need for external incisions, with less morbidity and a 
more efficient approach for the optical neuropathy. Our 
goal with this paper is to describe the surgical technique, 
focusing on its advantages and disadvantages.
Preoperative:
Basically, besides routine evaluation carried out 
for any type of surgery, endoscopic assessment and ra-
diology are paramount. Through endoscopy we may see 
alterations such as septal deviations and the presence of 
infections, which may be treated clinically or during the 
surgical procedure. The coronal slice in the CT scan is 
useful to access how aerated the ethmoid is, the integrity 
and slope of the ethmoid ceiling, as well as the orbital 
medial wall (it is important to evaluate the height of the 
posterior ethmoid sinus and its relation with the maxil-
lary ceiling and determine whether the posterior ethmoid 
expands posteriorly and superiorly, involving the optical 
nerve and or the internal carotid artery), the thickness of 
the orbital floor (the thicker it is, the harder it is to remove 
it endoscopically through middle meatal antrostomy), the 
skull base situation. The axial view is useful to show the 
relation between the posterior ethmoid artery, the optical 
nerve and the orbital apex. Both views show the hyper-
trophy of the extrinsic eye muscles (Figure 1).
SURGICAL TECHNIQUE 
Under general anesthesia, the patient is initially 
positioned in dorsal decubitus, with the head slightly 
tilted upwards, in 30º. We inject the anesthetic agent on 
the lateral wall placing cotton balls with vasoconstrictor 
agents in the nasal cavities. If there is septum deviation 
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we correct it prior to the main endoscopic procedure. The 
orbital decompression (OD) starts in the unciform process 
incision, with complete ethmoidectomy11. We proceed 
with middle meatotomy as broadly as possible, in order 
to visualize the orbital floor, down to the posterior max-
illary wall, enough to accommodate the orbital content 
and prevent obstructive maxillary sinusitis. We use the 
45º endoscope to see the infraorbitary nerve in its canal, 
along the ceiling of the maxillary sinus, because this nerve 
represents the lateral limit for bone removal. Following 
that, we proceed with a transethmoidal sphenoidectomy, 
and anteriorly, we open the frontal recess. One should pay 
special attention to Onodi’s cells, where the optical nerve 
may bulge. The anterior limit corresponds to the frontal 
maxillary process, close to the nasolacrimal duct. The su-
perior limit corresponds to the floor of the anterior cranial 
fossa, where the ethmoidal arteries represent an important 
anatomical reference point. Inferiorly, the insertion of the 
inferior turbinate is the limit. The middle turbinate may be 
removed in order to optimize the orbital content prolapse. 
The lamina papyracea is then skeletonized and removed 
with the periosteum elevator, which easily separates it 
from the periorbital tissue (Figure 2).
The lamina is carefully removed in order to avoid 
lacerations in the periorbital area, where there may be fat 
tissue herniations which may impair the periorbital skel-
etonization. We proceed with the dissection all the way to 
the posterior ethmoid bundle, close to the optical nerve, 
where the bone is thicker. Here we find the Zinn annulus, 
where the extra-ocular muscles are inserted, and certainly 
the optical nerve path. With the 45º endoscope we remove 
the orbital floor down to the infra-orbital vascular-nervous 
bundle, which is our lateral dissection limit. We dissect as 
posteriorly as possible.
Once the periorbit is fully dissected and exposed, 
we make an incision in order to allow a free fat prolapse 
from the periorbital tissue. We proceed making two to 
four longitudinal, postero-anterior and infero-superior 
periorbital incisions. This sequence reduces the chance of 
the herniated fat impair the surgeon’s view. One should 
be careful with the superficial unciform process removal 
in order to avoid penetrating the intraorbitary content. At 
the end of the procedure there is fat and orbital content 
extrusion (Figure 3). If necessary, we may proceed with 
lateral decompression at this stage, because through the 
medial decompression, it will be easy to expose the lat-
eral bone wall. There is no need for nasal packing. The 
patient may be discharged on the next day following the 
procedure, with oral antibiotics (amoxicillin for 10 days) 
and saline solution nasal spray.
DISCUSSION
The progress of endoscopic procedures has opened 
new possibilities for otorhinolaryngologists to work in dif-
ferent areas that were considered difficult, such as dacrio-
cistorrinostomy, orbital decompression and optical nerve 
decompression, in a safe and minimally invasive way.
This technique was first described by Kennedy et 
al. in the early 90’s10. The endoscopic approach allows an 
excellent view for a safe removal of the medial and inferior 
orbital wall, specially in the regions of the ethmoidal ceiling 
and orbital apex. The endoscopic orbital decompression 
is based on a broad middle meatotomy in order to allow 
broad view of the orbital floor.
As to the transantral approach, the endoscopic orbit-
al decompression does not cause hypoesthesia secondary 
to infra-orbitary nerve lesion, and causes fewer incidences 
of hypoglobus, thus allowing for a shorter hospital stay 
when compared to the traditional Walsh-Ogura7 procedure. 
It also allows a more effective decompression of the orbit 
apex, specially indicated in cases of orbital neuropathy.
The most difficult surgical step is the removal of 
the medial portion of the orbital floor, medially to the in-
fraorbitary nerve, due to an excessive thickness that may 
be present on the floor; however it may be previously 
evaluated through the CT scan. Bone resections laterally 
to the infraorbitary cause little proptosis reduction and 
increase the incidence of hypoglobus and diplopia. Michel 
et al.4 also described the bilateral removal of the middle 
conchae during decompression, aiming at increasing the 
area for orbit content extrusion.
Endoscopically we have been able to achieve vari-
able proptosis retraction, between 3.2 to 4.7 millimeters, 
as we can see on table14,10,12,13. However, greater retractions 
may be reached if external approaches are associated, such 
as the removal of the lateral orbital wall.
Among the disadvantages, we mention a higher 
incidence of diplopia, which may be surgically corrected 
later on, and the potential development of sinusitis or 
secondary mucocele14-18.
The most frequently reported complications with 
this procedure are sinusitis or frontal or maxillary mu-
cocele, CSF fistulas, lesion of the nasolacrimal duct, stra-
bismus and diplopia, which may occur in 15 to 60% of 
Table 1. Reported series of proptosis retraction through endoscopic-
only orbital decompression.
Series # of orbits
Average proptosis 
reduction
Kennedy et al.10 5 4,7mm
Michel et al.4 12 3,3mm
Lund et al.12 24 4,4mm
Metson & Shore13 6 3,2mm
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Figure 1a. CT scans, axial views (A) of a patient with Graves’ ophthal-
mopathy, showing the hypertrophy of the extrinsic ocular muscles.
Figure 1b. CT scans, coronal views (B) of a patient with Graves’ 
ophthalmopathy, showing the hypertrophy of the extrinsic ocular 
muscles.
the cases. The latter may have spontaneous resolution in 
three to four weeks, but it may also appear later on, due 
to disease progress. In these cases, there is the need for 
strabismus correction.
FINAL COMMENTS
In the past this procedure was carried out externally, 
but currently the orbital decompression may be performed 
through an endoscopic approach, a minimally invasive 
procedure, allowing the removal of the infero-medial all 
without external cuts. It is a safe procedure for the treat-
ment of thyroid orbitopathy, bearing less morbidity, avoid-
ing lesions to the nasolacrimal and nasofrontal duct, or the 
infraorbitary nerve, allowing a proptosis reduction of 3 to 
4 mm. This technique allows a maximum decompression 
of the orbital apex in cases or orbital neuropathy. How-
ever, it is necessary to have a trained surgeon in order to 
achieve good results and avoid complications.
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